Long-term RNA interference and its application to hepatitis B virus

Journal of Digestive Diseases

Volumn 10, Issue 3, 2009, Pages 165-171

  Pan, Jin Shui ^a   Wang, Xiao Zhong ^b   Ren, Jian Lin ^a  

^a XIAMEN UNIVERSITY   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Antiviral agents; Effects; Gene silencing; Hepatitis B virus; Long term; RNA interference

Indexed keywords

APOLIPOPROTEIN A1; DOUBLE STRANDED RNA; LUCIFERASE; RNA POLYMERASE II; SHORT HAIRPIN RNA; TRANSACTIVATOR PROTEIN; VIRUS VECTOR;

CELL CYCLE ARREST; DNA DAMAGE; DNA TRANSPOSITION; DOWN REGULATION; EUKARYOTE; EXON; GENE CASSETTE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INSERTION; GENE SILENCING; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL NUCLEUS; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; RNA DEGRADATION; RNA INTERFERENCE; RNA VECTOR; SIGNAL TRANSDUCTION; TRANSPOSON; VIRAL GENE DELIVERY SYSTEM; VIRUS REPLICATION;

DNA, VIRAL; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MUTAGENESIS, INSERTIONAL; RNA, SMALL INTERFERING;

EID: 68149158913     PISSN: 17512972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-2980.2009.00381.x     Document Type: Review

References (64)

1. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998; 391: 806-11.
2. Coburn GA, Cullen BR. Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J Virol. 2002; 76: 9225-31.
3. Ge Q, McManus MT, Nguyen T et al. RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proc Natl Acad Sci USA. 2003; 100: 2718-23.
4. Liu J, Fan D. Hepatitis B in China. Lancet. 2007; 369: 1582-3.
5. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007; 45: 507-39.
6. Chan HL, Leung NW, Hui AY et al. A randomized, controlled trial of combination therapy for chronic hepatitis B: Comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone. Ann Intern Med. 2005; 142: 240-50.
7. Janssen HL, van Zonneveld M, Senturk H et al. PEGylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: A randomised trial. Lancet. 2005; 365: 123-9.
8. Schalm SW, Heathcote J, Cianciara J et al. Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: A randomised trial. Gut. 2000; 46: 562-8.
9. Konishi M, Wu CH, Wu GY. Inhibition of HBV replication by siRNA in a stable HBV-producing cell line. Hepatology. 2003; 38: 842-50.
10. McCaffrey AP, Nakai H, Pandey K et al. Inhibition of hepatitis B virus in mice by RNA interference. Nat Biotechnol. 2003; 21: 639-44.
11. Ying C, De Clercq E, Neyts J. Selective inhibition of hepatitis B virus replication by RNA interference. Biochem Biophys Res Commun. 2003; 309: 482-4.
12. Braasch DA, Paroo Z, Constantinescu A et al. Biodistribution of phosphodiester and phosphorothioate siRNA. Bioorg Med Chem Lett. 2004; 14: 1139-43.
13. Downward J. RNA interference. BMJ. 2004; 328: 1245-8.
14. Stevenson M. Therapeutic potential of RNA interference. N Engl J Med. 2004; 351: 1772-7.
15. Leung RK, Whittaker PA. RNA interference: From gene silencing to gene-specific therapeutics. Pharmacol Ther. 2005; 107: 222-39.
16. Soutschek J, Akinc A, Bramlage B et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature. 2004; 432: 173-8.
17. Morrissey DV, Blanchard K, Shaw L et al. Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication. Hepatology. 2005; 41: 1349-56.
18. Ge Q, Filip L, Bai A, Nguyen T, Eisen HN, Chen J. Inhibition of influenza virus production in virus-infected mice by RNA interference. Proc Natl Acad Sci U S A. 2004; 101: 8676-81.
19. Yang N, Zhang L, Kazazian HH Jr. L1 retrotransposon-mediated stable gene silencing. Nucleic Acids Res. 2005; 33: E57.
20. Heggestad AD, Notterpek L, Fletcher BS. Transposon-based RNAi delivery system for generating knockdown cell lines. Biochem Biophys Res Commun. 2004; 316: 643-50.
21. DaRocha WD, Otsu K, Teixeira SM, Donelson JE. Tests of cytoplasmic RNA interference (RNAi) and construction of a tetracycline-inducible T7 promoter system in Trypanosoma cruzi. Mol Biochem Parasitol. 2004; 133: 175-86.
22. Bain JR, Schisler JC, Takeuchi K, Newgard CB, Becker TC. An adenovirus vector for efficient RNA interference-mediated suppression of target genes in insulinoma cells and pancreatic islets of Langerhans. Diabetes. 2004; 53: 2190-4.
23. Boden D, Pusch O, Lee F, Tucker L, Ramratnam B. Efficient gene transfer of HIV-1-specific short hairpin RNA into human lymphocytic cells using recombinant adeno-associated virus vectors. Mol Ther. 2004; 9: 396-402.
24. Michel U, Malik I, Ebert S, Bahr M, Kugler S. Long-term in vivo and in vitro AAV-2-mediated RNA interference in rat retinal ganglion cells and cultured primary neurons. Biochem Biophys Res Commun. 2005; 326: 307-12.
25. Duxbury MS, Ito H, Benoit E, Zinner MJ, Ashley SW, Whang EE. Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase: A novel therapeutic strategy in pancreatic cancer. Surgery. 2004; 136: 261-9.
26. Schuck S, Manninen A, Honsho M, Fullekrug J, Simons K. Generation of single and double knockdowns in polarized epithelial cells by retrovirus-mediated RNA interference. Proc Natl Acad Sci USA. 2004; 101: 4912-7.
27. Abbas-Terki T, Blanco-Bose W, Deglon N, Pralong W, Aebischer P. Lentiviral-mediated RNA interference. Hum Gene Ther. 2002; 13: 2197-201.
28. An DS, Xie Y, Mao SH, Morizono K, Kung SK, Chen IS. Efficient lentiviral vectors for short hairpin RNA delivery into human cells. Hum Gene Ther. 2003; 14: 1207-12.
29. Raoul C, Abbas-Terki T, Bensadoun JC et al. Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS. Nat Med. 2005; 11: 423-8.
30. Rubinson DA, Dillon CP, Kwiatkowski AV et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet. 2003; 33: 401-6.
31. Faivre-Rampant O, Gilroy EM, Hrubikova K et al. Potato virus X-induced gene silencing in leaves and tubers of potato. Plant Physiol. 2004; 134: 1308-16.
32. Constantin GD, Krath BN, MacFarlane SA, Nicolaisen M, Johansen IE, Lund OS. Virus-induced gene silencing as a tool for functional genomics in a legume species. Plant J. 2004; 40: 622-31.
33. Izsvak Z, Ivics Z, Plasterk RH. Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates. J Mol Biol. 2000; 302: 93-102.
34. Ding S, Wu X, Li G, Han M, Zhuang Y, Xu T. Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice. Cell. 2005; 122: 473-83.
35. Slotkin RK, Freeling M, Lisch D. Heritable transposon silencing initiated by a naturally occurring transposon inverted duplication. Nat Genet. 2005; 37: 641-4.
36. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell. 1993; 72: 971-83.
37. Chen ZJ, Kren BT, Wong PY, Low WC, Steer CJ. Sleeping Beauty-mediated down-regulation of huntingtin expression by RNA interference. Biochem Biophys Res Commun. 2005; 329: 646-52.
38. Yant SR, Meuse L, Chiu W, Ivics Z, Izsvak Z, Kay MA. Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nat Genet. 2000; 25: 35-41.
39. Wang J, Tekle E, Oubrahim H, Mieyal JJ, Stadtman ER, Chock PB. Stable and controllable RNA interference: Investigating the physiological function of glutathionylated actin. Proc Natl Acad Sci USA. 2003; 100: 5103-6.
40. Alibu VP, Storm L, Haile S, Clayton C, Horn D. A doubly inducible system for RNA interference and rapid RNAi plasmid construction in Trypanosoma brucei. Mol Biochem Parasitol. 2005; 139: 75-82.
41. Matthess Y, Kappel S, Spankuch B, Zimmer B, Kaufmann M, Strebhardt K. Conditional inhibition of cancer cell proliferation by tetracycline-responsive, H1 promoter-driven silencing of PLK1. Oncogene. 2005; 24: 2973-80.
42. Gupta S, Schoer RA, Egan JE, Hannon GJ, Mittal V. Inducible, reversible, and stable RNA interference in mammalian cells. Proc Natl Acad Sci U S A. 2004; 101: 1927-32.
43. Coumoul X, Li W, Wang RH, Deng C. Inducible suppression of Fgfr2 and Survivin in ES cells using a combination of the RNA interference (RNAi) and the Cre-LoxP system. Nucleic Acids Res. 2004; 32: E85.
44. Hepatitis B. Fact sheet WHO No. 204. Geneva: World Health Organization, October 2000. Cited 25 Nov. 2008. Available from URL: http://www.who.int/ mediacentre/factsheets/fs204/en/index.html.
45. Liaw YF, Leung N, Guan R et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2005 update. Liver Int. 2005; 25: 472-89.
46. Kim K, Kim KH, Kim HH, Cheong J. Hepatitis B virus X protein induces lipogenic transcription factor SREBP1 and fatty acid synthase through the activation of nuclear receptor LXRalpha. Biochem J. 2008; 416: 219-30.
47. Lei JH, He XE, Yang X et al. Effects of HBV X gene and arsenic trioxide on the expression of p53 in cultured HepG2 cells. Chin Med J (Engl). 2007; 120: 2181-4.
48. Jenke AC, Wilhelm AD, Orth V, Lipps HJ, Protzer U, Wirth S. Long-term suppression of hepatitis B virus replication by short hairpin RNA expression using the scaffold/matrix attachment region-based replicating vector system pEPI-1. Antimicrob Agents Chemother. 2008; 52: 2355-9.
49. Giering JC, Grimm D, Storm TA, Kay MA. Expression of shRNA from a tissue-specific pol II promoter is an effective and safe RNAi therapeutic. Mol Ther. 2008; 16: 1630-6.
50. Wen WH, Liu JY, Qin WJ et al. Targeted inhibition of HBV gene expression by single-chain antibody mediated small interfering RNA delivery. Hepatology. 2007; 46: 84-94.
51. Kim SI, Shin D, Choi TH et al. Systemic and specific delivery of small interfering RNAs to the liver mediated by apolipoprotein A-I. Mol Ther. 2007; 15: 1145-52.
52. Rauschhuber C, Xu H, Salazar FH, Marion PL, Ehrhardt A. Exploring gene-deleted adenoviral vectors for delivery of short hairpin RNAs and reduction of hepatitis B virus infection in mice. J Gene Med. 2008; 10: 878-89.
53. Ren GL, Fang Y, Ma HH et al. The short hairpin RNA driven by polymerase II suppresses both wild-type and lamivudine-resistant hepatitis B virus strains. Antivir Ther. 2007; 12: 865-76.
54. Li GQ, Xu WZ, Wang JX, Deng WW, Li D, Gu HX. Combination of small interfering RNA and lamivudine on inhibition of human B virus replication in HepG2.2.15 cells. World J Gastroenterol. 2007; 13: 2324-7.
55. Wang J, Theunissen TW, Orkin SH. Site-directed, virus-free, and inducible RNAi in embryonic stem cells. Proc Natl Acad Sci USA. 2007; 104: 20850-5.
56. Rangasamy D, Tremethick DJ, Greaves IK. Gene knockdown by ecdysone-based inducible RNAi in stable mammalian cell lines. Nat Protoc. 2008; 3: 79-88.
57. Jackson AL, Bartz SR, Schelter J et al. Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol. 2003; 21: 635-7.
58. Saxena S, Jonsson ZO, Dutta A. Small RNAs with imperfect match to endogenous mRNA repress translation. Implications for off-target activity of small inhibitory RNA in mammalian cells. J Biol Chem. 2003; 278: 44312-9.
59. Qiu S, Adema CM, Lane T. A computational study of off-target effects of RNA interference. Nucleic Acids Res. 2005; 33: 1834-47.
60. Hacein-Bey-Abina S, von Kalle C, Schmidt M et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med. 2003; 348: 255-6.
61. Marshall E. Gene therapy. Second child in French trial is found to have leukemia. Science. 2003; 299: 320.
62. Das AT, Brummelkamp TR, Westerhout EM et al. Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J Virol. 2004; 78: 2601-5.
63. Wu HL, Huang LR, Huang CC et al. RNA interference-mediated control of hepatitis B virus and emergence of resistant mutant. Gastroenterology. 2005; 128: 708-16.
64. Grimm D, Streetz KL, Jopling CL et al. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature. 2006; 441: 537-41.